Company Filing History:
Years Active: 2016
Title: Arieh Sierra Cohen: Innovator in Neonatal Screening
Introduction
Arieh Sierra Cohen is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of neonatal screening, particularly in the diagnosis of galactosemia. Her innovative approach has the potential to improve early detection and treatment of this metabolic disorder in newborns.
Latest Patents
Cohen holds a patent for a method of diagnosing galactosemia in neonatal screening. This method involves determining GAL-1-P concentrations in blood samples from neonates before they reach 5-7 days of life. By removing interfering compounds, her technique allows for a more specific and accurate determination of GAL-IP levels using mass spectrometry. This advancement is crucial for investigating samples from infants who have not yet achieved a steady state of GAL-IP.
Career Highlights
Arieh Sierra Cohen is associated with the Statens Serum Institut, where she continues to work on innovative solutions in the field of neonatal health. Her dedication to improving diagnostic methods showcases her commitment to advancing medical science and enhancing patient care.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Arieh Sierra Cohen's contributions to neonatal screening through her patented method for diagnosing galactosemia highlight her role as a leading innovator in the medical field. Her work is poised to make a significant impact on the early detection and management of metabolic disorders in newborns.